AstraZeneca Continues to Help Tennesseans in Need through Dispensary of Hope

--Programs Expand Access to Prescription Medications--

NASHVILLE, Tenn.--(BUSINESS WIRE)-- The Dispensary of Hope, a not-for-profit social venture that provides sustainable access to medicine for uninsured communities, today announced a continued collaboration with AstraZeneca under one of the company’s prescription savings programs—AZ&Me™ for healthcare facilities.

AstraZeneca is a partner of the Dispensary’s Continued Access Program that joins the efforts of pharmaceutical companies and other healthcare organizations to provide access to more than 2,000 medications to treat a variety of chronic conditions, including heart disease, diabetes, and neurological disorders. The program offers a comprehensive solution by centralizing patient enrollment and coordinating prescription fulfillment, while providing on-going support.

“Now, more than ever, we need to help people in Tennessee get the medicines they need,” said Jennifer McGovern, Director, Patient Assistance Programs, AstraZeneca Pharmaceuticals LP. “With the impact of recent flooding and changes to the state Medicaid program, those who may have never thought they would need patient assistance are looking to the Dispensary of Hope as a vital resource.”

Flood victims in need of securing medications can simply call 1-888-428-HOPE (4673) to qualify for the program. Patients need only to answer a series of basic questions, including name, date of birth, name of medications, physician’s name, and the pharmacy where they currently fill prescriptions. The patient then goes to a participating Dispensary pharmacy to pick up the prescriptions. If they are unable to access a participating pharmacy, the 1-888 number will provide alternative options.

“AstraZeneca has been involved with the Dispensary of Hope since the beginning,” said Scott Cornwell, Chief Operating Officer of the Dispensary of Hope. “We value our ongoing collaboration with AZ&Me and are especially grateful that the program recognizes the state’s current condition and is making it easy for new and existing patients to get their medications.”

About the Dispensary of Hope

Founded in 2003, the Dispensary of Hope is a not-for-profit social venture that provides sustainable access to medicine for underinsured communities through a growing network of dispensing sites across the country. The Dispensary has collected and distributed tens of millions of dollars worth of pharmaceuticals and filled more than 200,000 prescriptions for patients who otherwise couldn’t afford them. For more information, visit www.dispensaryofhope.org or call 1-888-428-HOPE (4673).

About AZ&Me for Healthcare Facilities

The AZ&Me™ Prescription Savings program for healthcare facilities provides medicines free of charge to community free clinics, community health centers, hospitals and other qualifying facilities that serve the uninsured. The program is available to non-profit organizations that have a licensed outpatient pharmacy or dispensary on site and meet other program criteria. Patients are eligible for AstraZeneca medicines through this program if they do not have prescription drug coverage and have a household income at or below $30,000 for an individual or $60,000 for a family of four. To learn if your organization qualifies for the AZ&Me™ Prescription Savings program for healthcare facilities, please call 1-866-325-8198. Program specialists are available Monday through Friday between the hours of 9:00 AM and 5:00 PM EST.



CONTACT:

Dispensary of Hope
Lauren Fulton, 615-254-0575
or
AstraZeneca
Tiffany Burke, 302-885-4995
610-209-7253 (mobile)

KEYWORDS:   United States  North America  Tennessee

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Philanthropy  Foundation

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.